Small Molecules
1 November 2017
RedHill Biopharma and IntelGenx Submit New Drug Application to FDA for RIZAPORT® for Migraines1 November 2017
Cristal Therapeutics Progresses Nanomedicine CriPec®-docetaxel to Phase 1b Development in Patients with Solid Tumours1 November 2017
US FDA approves AstraZeneca’s Calquence (acalabrutinib) for adult patients with previously-treated mantle cell lymphoma31 October 2017
Chi-Med Initiates FRUTIGA, a Phase III Trial of Fruquintinib in Second-Line Gastric Cancer31 October 2017
Impel NeuroPharma Announces First Patient Dosed in Phase 1 Clinical Trial of INP104 for Treatment of Acute Migraine Headache31 October 2017
Catalyst Pharmaceuticals Completes Enrollment in Second Phase 3 Trial of Firdapse(R) in Patients with Lambert-Eaton Myasthenic Syndrome31 October 2017
Daiichi Sankyo Announces ENLIVEN Phase 3 Study of Pexidartinib Met Primary Endpoint in Tenosynovial Giant Cell Tumor30 October 2017
Rgenix Reports Preliminary Phase 1a/b Clinical Data Demonstrating Immune-stimulatory Activity with RGX-104 in Advanced Cancer Patients30 October 2017
Can-Fite Announces Enrollment of First Patient in its ACRobat Phase III Trial of Piclidenoson in Rheumatoid Arthritis30 October 2017
Sierra Oncology Reports Preclinical Data for its Chk1 Inhibitor SRA737 Supporting its Ongoing Clinical Development Strategy30 October 2017
Bayer receives FDA approval for Xarelto® 10 mg once daily for the extended treatment of venous thromboembolism29 October 2017
Kura Oncology Development Candidate KO-539 Shows Robust Preclinical Anti-Tumor Activity in NPM1- and DNMT3A-Mutant AML28 October 2017
Sunovion Presents Data from Phase 3 Studies of Latuda® (lurasidone HCl) in Children and Adolescents with Bipolar Depression28 October 2017
Novartis PARADIGMS data show children and adolescents with MS had an 82% lower relapse rate with Gilenya® vs. interferon beta-1aNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports